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Abstract
Introduction: Over 8000 cases of tuberculosis (TB) are diagnosed annually in Poland. People infected with Mycobacterium
tuberculosis (MTB) have a risk of active disease of around 10% during their whole life, and the risk is highest in the first two
years after infection. Recognizing infection before TB disease development enables prophylaxis against its activation and
ceases transmission of infection. Knowledge about the proportion of infected people in the population is crucial to predict the
number of new cases of active disease.
Materials and methods: The prevalence of latent TB infection (LTBI) was tested in 700 healthy adult inhabitants of the
Mazowieckie province in different age groups, using both tuberculin skin test (TST) and interferon gamma release assay
(IGRA). Commercial test QuantiFERON®-TB-Gold In Tube (QFT) was used. All participants were mandatorily BCG vaccinated
according to the Polish vaccination schedule.
Results: Twenty-three per cent of participants tested positively for QFT, which was significantly less than for TST (50.3%).
The prevalence of positive QFT results increased with age, as well as the incidence of TB in Poland. Positive QFT was most
frequent in the oldest age group (48.8%) and rarest in the youngest (7.1%). Conversely, positive TST occurred more often in
younger participants (45%), who rarely suffer from TB. Among people over 60, with the highest TB incidence rate, only
33.8% tested positively with TST. Concordance between both tests was low, with a kappa value of 0.198. The prevalence of
LTBI defined as positive QFT among health care workers (HCW) was significantly higher than among other participants
(32.2% v. 20.4%, p < 0.01).
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Conclusions: LTBI was diagnosed in 23.3% of the tested population of the Mazowieckie province. QFT is a better tool for
diagnosing LTBI as it shows a positive correlation with age (as the incidence of TB disease does). Concordance between
both tests is low. The prevalence of LTBI in HCW is higher than in other participants.
Key words: latent tuberculosis infection, tuberculin skin test, interferon gamma release assay
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Introduction
Every year, about 8000 individuals in Poland
are diagnosed with tuberculosis (TB). Nearly one
half of this group is sputum-positive and constitu-
tes a source of infection for other individuals. In-
dividuals infected with Mycobacterium tuberculo-
sis constitute the source pool for new cases of the
disease. The most important aim of anti-tubercu-
losis programs is the detection of active TB as ear-
ly as possible to inhibit the transmission of the
infection to healthy individuals, by means of ear-
ly treatment and isolation. The risk of the disease
in an infected person does not exceed 10%, is at
the highest level during the first two years follo-
wing infection, and is sustained throughout their
whole life. Along with the improvements in the
epidemiological profile of tuberculosis, i.e. the re-
duction of incidence and morbidity, the anti-tuber-
culosis programs are directed towards the detec-
tion of infection in healthy individuals. This faci-
litates undertaking of prophylactic measures aimed
at prevention of tuberculosis development in in-
dividuals already infected with Mycobacterium tu-
berculosis.
For 100 years, infection with Mycobacterium
tuberculosis has been detected by tuberculin skin
test (TST). Following intradermal injection of tu-
berculin, infected individuals react with infiltra-
tion at the injection site, i.e. with a positive TST
result. The result of TST is scored as positive with
a diameter of induration ranging from 5 to 15 mm,
depend on population tested and national guideli-
nes. The statement that a positive TST result is pro-
of of tuberculosis infection is true only in popula-
tions in which no anti-tuberculosis vaccinations
(bacillus Calmette-Guerin, BCG) are used [1]. Me-
taanalysis of many tests that have collected tho-
usands of observations of both BCG-vaccinated and
non-vaccinated individuals have shown that vac-
cination, particularly if performed after infancy (as
it used to be until recently in Poland), leads to lar-
ger TST induration and this reactivity tend to per-
sist for many years [2]. The main cause of falsepo-
sitive TST results is the fact that tuberculin is a
mixture of about 200 antigens present not only in
acid-fast bacilli of M. tuberculosis, but also in the
BCG strain used for vaccination as well as in other
non-tuberculous mycobacteria common in the hu-
man environment, e.g. in tap water.
A solution to this problem is to use, in the
detection tests, such antigens that are specific to
M. tuberculosis and are not present in the BCG stra-
in or in most non-tuberculous bacilli. Such anti-
gens are ESAT-6 and CFP-10.
The principle of the tests is stimulation of lym-
phocytes in a sample of blood collected from a
person suspected to be infected with M. tubercu-
losis with ESAT-6 and CFP-10. The response is
measured by the amount of produced interferon-
gamma (IFNg) and stimulated lymphocyte counts.
Tests assessing IFNg production are generally
known as interferon-gamma release assays
(IGRAs). An advantage of these assays is that a
previous BCG vaccination has no impact on the
result [3–6]. Determination of the incidence of M.
tuberculosis infection in particular populations is
of crucial importance for prognosis of future tuber-
culosis morbidity (incidence). Thus, it may facili-
tate planning the management aimed at the elimi-
nation of tuberculosis from our population. A re-
liable test for detection of M. tuberculosis infection
in healthy individuals allows the selection of in-
dividuals in whom prophylactic management may
be initiated with the purpose of preventing the
infected person from developing active tuberculo-
sis. Such management is increasingly common in
countries with a small percentage of infected in-
dividuals in the population.
The aim of the present study was a prospecti-
ve assessment of the incidence of M. tuberculosis
infection in groups of healthy adults from various
communities by means of interferon gamma rele-
ase stimulated by specific, recombinant M. tuber-
culosis antigens (ESAT-6 and CFP-10) and TST re-
sults. Another goal was to evaluate the diagnostic
usefulness of the QuantiFE-RON®-TB-Gold In
Tube (QFT) test in the detection of M. tuberculosis
infection in different study groups as compared to
the TST.
Jan Kuś et al., Ocena częstości występowania zakażenia prątkiem gruźlicy
409www.pneumonologia.viamedica.pl
Material and methods
The study was conducted in three groups of
healthy adult residents of Mazowieckie province
who, having obtained written and oral information
regarding the purpose and the nature of the study,
gave in writing their consent to participate. The
authors of the study obtained the approval of the
Bioethics Committee of the Institute of Tubercu-
losis and Lung Diseases in Warsaw.
The studied individuals originated from the
following communities:
1. blood donors and healthy individuals registe-
red at a family physician’s practice (individu-
al medical practice in Mazowieckie province);
2. healthcare professionals;
3. penitentiary inmates.
After obtaining consent, the following procedures
were performed on the volunteers in the fol-
lowing order:
1. history including current diseases, HIV infec-
tion, intake of immunosuppressive drugs and
contact with tuberculosis, history of tubercu-
losis, and BCG vaccinations;
2. blood collection for IGRA tests;
3. tuberculin skin test.
Individuals in whom diseases or conditions of
potentially significant impact on immunity, such
as pregnancy, insulin-dependent diabetes, renal in-
sufficiency, cancer, HIV infection, intake of immu-
nosuppressive drugs, including glucocorticosteroids
were identified, were not included in the study.
QuantiFERON®-TB-Gold In Tube Test
Commercial QuantiFERON®-TB-Gold In Tube
tests available from Cellestis (Australia) were used.
All test procedures were performed in accordance
with the manufacturer’s instructions.
Vein blood was collected by a qualified per-
sonnel into two heparinized tubes from the kit: one
tube with walls coated with ESAT-6, CFP-10 and
TB7.7 antigens, and the other tube containing pure
physiological saline with phosphate buffer (nega-
tive control). Samples were numerically coded.
The diagnostic technician performing the IGRA test
and the nurse reading the TST results did not know
the results of other tests or survey data.
Following blood collections, tubes were flip-
ped upside down several times so that blood tho-
roughly washed the tube walls coated with anti-
gens specific to Mycobacterium tuberculosis. Imme-
diately after collection, samples were placed in a
portable heater (MOBICOOL TROPICOOL-CLAS-
SIC model TC-18UG-12), where they were subjec-
ted to incubation at 37°C for 16-24 hours in an
upright position. Next, the blood was centrifuged
for 15 minutes at +4°C and at a speed of 3000 RPM
(High Speed Brushless Centrifuge MPW-350R from
MPW Med. Instruments). Samples were stored at
–40°C until IFNg levels were determined by ELI-
SA. The assay was performed by a qualified labo-
ratory diagnostic technician according to the ma-
nufacturer’s recommendations.
IFNg concentrations in tested samples were
calculated from a reference curve using KC junior
software from Bio-Tek Instruments 1998–2001.
Final results were obtained after subtraction of a
blank sample value from the test sample value. A
zero value was assumed for negative results. A
positive test result was defined as an IFNg concen-
tration of 0.35 IU/ml or more, according to the
manufacturer’s recommendations. An indetermi-
nate result was given if the IFNg concentration in
the negative control was 8.0 IU/ml or more.
Tuberculin skin test
The tuberculin skin test was performed by in-
tradermal injection of 0.1 ml — 2 units of tubercu-
lin PPD RT23 into the dorsal surface of the forearm.
Tuberculin was manufactured by Statens Serum In-
stitute (Copenhagen, Denmark). The result was read
after 72 hours by measuring the diameter of the in-
filtration transversely to the long axis of the fore-
arm. Tuberculin was injected and the results were
read by the same person, with many years of expe-
rience, routinely performing TSTs in the Institute
of Tuberculosis and Lung Diseases in Warsaw.
Statistical analysis
Descriptive statistics for the tested variables
are presented in tables as absolute numbers and
percentages.
Incidences of positive tests in groups determi-
ned by the studied factors were compared by me-
ans of c2 test or Fisher’s exact test (in case of cell
counts being too low in the contingency tables,
preventing the use of the c2 test). An analysis of
factors affecting the risk of infection was also per-
formed. Logistic regression analysis was used for
this purpose. The analysis was performed in three
groups: 1) ZDR — healthy persons with no asso-
ciation with healthcare; 2) SŁZ — healthcare pro-
fessionals; and 3) ZKR — penitentiary inmates (pri-
soners). At the first stage of the analysis, the im-
pact of gender and age was studied. The impacts
of the remaining factors were assessed in models
taking into consideration the age and gender of
patients. The results were presented as hazard ra-
tios with 95% confidence intervals and p values.
Statistical significance was defined as p £ 0.05.
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The assessment of the level of significance for
the relationship between TST and QFT test results
was performed using the concordance coefficient
k. Values of k below 0 indicate lack of conformity,
values in the range of 0–0.2 indicate very poor agre-
ement, values in the range of 0.21–0.4 indicate poor
agreement, values in the range of 0.41–0.6 indica-
te moderate agreement, values in the range of 0.61-
0.8 indicate significant agreement, and values abo-
ve 0.81 indicate excellent agreement.
Calculations were performed using SPSS sta-
tistical packages for Windows 12.0 (SPSS, Inc.,
Chicago, Illinois).
Results
A total of 700 subjects took part in the study.
Due to incomplete demographical data, 43 subjects
were excluded from analysis. Among the remaining
657 subjects, QFT test results were obtained in 621
individuals. The reasons for missing results in 36
subjects were inability to collect blood or acciden-
tal sample destruction (29 cases) and indetermi-
nate test results (7 cases). TST results were obta-
ined in 487 of 657 subjects. The lack of TST re-
sults in 170 patients was due to the lack of con-
sent for tuberculin injection (154 patients) and not
reporting for test result reading despite having re-
ceived the injection (16 patients). Both QFT test
and TST results were obtained in 452 of 657 sub-
jects.
The study group of 657 subjects included 404
females (61.5%) and 253 males (38.5%). Age gro-
ups of 0–24 years, 25–44 years, 45–59 years, and
60 and more years were represented by 12.9%,
44.3%, 30.1%, and 12.6% of subjects, respective-
ly. The study subjects belonged to three different
communities assigned with the following abbrevia-
tions for the sake of simplification of the text and
tables:
1. ZDR: blood donors reporting at the Regional
Centre for Blood Donation and Treatment in
Warsaw and healthy individuals registered at
a family physician’s practice (individual me-
dical practice in the Mazowieckie province) —
374 subjects, accounting for 56.9% of the en-
tire study population. The age of subjects in
this group (mean ± SD) was 43.8 ± 17.0 years;
2. SŁZ: Healthcare professionals — employees of
microbiology labs processing material collec-
ted from tuberculosis patients and physicians
in contact with tuberculosis patients — 145
subjects, accounting for 22.1% of the entire
study population. The age of the subjects
(mean ± SD) was 42.1 ± 9.8 years;
3. ZKR: inmates of a penitentiary institution in
Warsaw — 138 subjects, accounting for 21.0%
of the entire study group. The age of the pri-
soners (mean ± SD) was 36.8 ± 12.8 years.
All study subjects were considered BCG-vac-
cinated. A scar on the arm that might indicate anti-
tuberculosis vaccination was found in 95% indi-
viduals. In the remaining 5% of subjects, BCG vac-
cination could not be excluded based on medical
history. It must be noted that in Poland starting
from 1955, the vaccination schedule provided
multiple BCG vaccinations from the neonatal age
to the age of 18. Since 2006, a single vaccination
has been administered on the 1st day of life, pur-
suant to the Ordinance of the Minister of Health.
Evaluation of M. tuberculosis infection incidence
based on the QFT test
Positive QFT test results were observed in 23.3%
of the entire study population. The incidence of po-
sitive QFT test results was compared between the
study groups: inmates, healthcare professionals expo-
sed to tuberculosis bacilli at work, and healthy indi-
viduals from outside these communities (Table 1).
A positive QFT test result was observed in 20.4% of
subjects in the ZDR group, 23.5% of subjects in the
ZKR group, and 32.2% of subjects in the SŁZ group.
The percentage of positive QFT test results in the SŁZ
group (healthcare professionals) was significantly
higher than in the ZDR group (p < 0.01), while the
incidence of M. tuberculosis infections assessed by
means of the QFT tests in the inmates group was the
same as in the ZDR group, i.e. in individuals from
outside healthcare professions or penitentiaries.
The analysis of the relationship between the
QFT test result and the age in the entire study po-
pulation is presented in Table 2. The percentage
of subjects with positive QFT test results increased
with age: from 7.1% in the youngest age group to
48.8% above the age of 60 (p < 0.001). Similar
trends were observed in all study groups when
analysed separately. The observation of M. tuber-
culosis infection being less common in younger
subjects compared to older subjects is consistent
with the tuberculosis incidence rates in the Polish
population. The risk of infection assessed on the
basis of positive QFT test result was also studied
in the ZDR group in an age- and gender-depen-
dent manner (Table 3). Gender was found to have
no significant effect on the test result, while the
probability of a positive QFT test result increased
with age in a statistically significant manner. M.
tuberculosis infection was nearly 5 times more
common in subjects above the age of 45 (p =
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Table 1. QFT results in different groups
QFT test Total
Negative Positive
Group Health care workers Number 80 38 118
(SŁZ) % 67.8% 32.2% 100.0%
Healthy voluntiers Number 292 75 367
(ZDR) % 79.6% 20.4% 100.0%
Correctional inmates Number 104 32 136
(ZKR) % 76.5% 23.5% 100.0%
Total Number 476 145 621
% 76.7% 23.3% 100.0%
p = 0,03 SŁZ v. ZDR p < 0,01 ZKR v. ZDR p = 0,46
Abbreviations in the text
Table 2. QFT results in different age groups (all participants)
QFT test Total
Negative Positive
Age group (years) £ 24 Number 78 6 84
% of age group 92.9% 7.1% 100.0%
25–44 Number 229 36 265
% of age group 86.4% 13.6% 100.0%
45–59 Number 127 63 190
% of age group 66.8% 33.2% 100.0%
≥ 60 Number 42 40 82
% of age group 51.2% 48.8% 100.0%
Total Number 476 145 621
% of age group 76.7% 23.3% 100.0%
p < 0,001
Abbreviations in the text
Table 3. Odds ratio of being infected based on positive
QFT result in the group of healthy voluntiers
(ZDR) adjusted for age and gender
OR 95% CI for OR p
Lower limit Upper limit
Woman 1.000
Man 1.006 0.58 1.747 0.982
Age £ 24 yrs 1.000
Age 25–44 yrs 1.362 0.454 4.081 0.581
Age 45–59 yrs 4.626 1.672 12.803 0.003
Age ≥ 60 yrs 12.126 4.362 33.713 < 0.001
Abbreviations in the text
0.003) and 12 times more common in subjects
above the age of 60 (p < 0.001) compared to sub-
jects below the age of 24.
Tuberculosis incidence rates with positive
smear results allowed the estimation of the annu-
al infection risk and, consequently, the approxi-
mate percentage of infected individuals by age
(year of birth). In line with the results of studies
conducted by Styblo et al. [7], the annual risk of
M. tuberculosis infection in populations with tu-
berculosis incidence rates confirmed by positive
smear results of 50/100,000 — is 1%. Estimated
percentages of individuals infected with tubercu-
losis in Poland, calculated from data in the Cen-
tral Registry for Tuberculosis [8, 9], are presented
in Table 4.
Assuming the estimated annual risk of infec-
tion, the percentage of individuals infected by the
age of 20 should not exceed 5%, and by the age of
45 — 25–28%. These incidences are similar to
data obtained from QFT test results in the study
population.
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Table 6. Positive TST results (cut off 10 mm and 15 mm)
in different age groups
Age group Number (n) TST ≥ 10 mm TST ≥ 15 mm
n (%) n (%)
£ 24 43 22 (51.2) 9 (20.9)
25–44 192 105 (54.7) 49 (25.5)
45–59 174 91 (52.3) 57 (32.8)
≥ 60 78 27 (34.6) 11 (14.1)
Total 487 245 (50.3) 126 (25.9)
Tuberculin skin test
There are no universal guidelines for TST re-
sult interpretation. According to the Polish guide-
lines defined in the National Anti-Tuberculosis
Program [10], the TST result is defined as positive
starting from 10 mm, while certain studies [11] and
US guidelines developed by Centers for Disease
Control and Prevention (CDC) and the American
Thoracic Society (ATS) assume that for individu-
als who are not in high risk groups, the result of
the TST is considered positive starting from the
induration diameter of 15 mm or more [12]. Table
5 presents the percentages of patients with TST
induration larger than 10 mm and larger than 15
mm in the entire population and individual sub-
groups.
If TST infiltration with a diameter of 10 mm
or more is to be assumed as the criterion for posi-
tive TST results in line with Polish guidelines,
tuberculosis infection should be diagnosed in more
than 50% of all study subjects, including 40.4% of
subjects in the healthy group.
Table 6 presents the incidence of positive TST
results for the criteria of more than 10 mm and
more than 15 mm in individual age groups of the
entire study population. Tuberculin infiltrations
larger than 10 mm were comparably common in
Table 5. Positive TST results (cut off 10 and 15 mm) in
the whole group and subgroups
Group tested Number (n) TST ≥ 10 mm TST ≥ 15 mm
n (%) n (%)
Whole group 487 245 (50.3) 126 (25.9)
ZDR* 213 86 (40.4) 34 (16)
SŁZ* 143 88 (61.5) 52 (36.4)
ZKR* 131 71 (54.2) 40 (30.5)
Abbreviations as in Table 1
all age groups (33.8–54.4%). Infiltrations larger
than 15 mm were less common, but also showed
no significant differences between the age groups
of under 24, 25–44, and 45–59 years (20–32.8%).
Of note is the very low incidence of positive TST
results with diameters of 15 mm and more in the
age group of 60 and more years (14.1%), which
shows that the test is not sufficiently sensitive in
elderly subjects.
Analysis of concordance between 10 mm
and 15 mm tuberculin skin test results and QFT
test results
Analysis of concordance of both assays was
performed in 452 subjects in whom both QFT and
TST results were available. The concordance of the
QFT and the TST results was analysed for the cri-
terion of 10 mm or more (Table 7) and 15 mm or
more (Table 8) in the entire patient population. The
concordance between the TST and the QFT test in
this study was very poor if TST results of 10 mm
or more were considered positive (k 0.198), and si-
gnificantly better when cut-off value of positive
result was 15 mm (k 0.323).
Sensitivity and specificity of the TST in con-
firmation of infection defined as positive QFT test
results was analysed (Figure 1). Test specificity
increased, but sensitivity decreased significantly
with the increase in TST infiltration diameter. The
course of the ROC curve suggests that the TST is
not the optimal test for diagnosing tuberculosis
infection.
Concordance between the QFT test results and
TST infiltrations was also analysed for the diame-
ter of 10 or more millimetres (Table 9) and 15 or
more millimetres (Table 10), in individual age gro-
ups. The poorest concordance between both tests
was observed in younger age groups (0-24 and 25–
44 years), in which the percentages of subjects with
positive TST results were high and exceeded 50%
for the cut-off diameter of 10 mm, while the per-
Table 4. Incidence of smear-positive pulmonary tubercu-
losis and estimated annual risk of infection in the
population
Year Incidence of Estimated annual risk
smear-positive of infection in %
cases/100.000/yr
1972 28.3 0.57
1980 21.9 0.44
1990 12.0 0.25
2000 8.7 0.17
2008 7.8 0.16
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Table 7. Concordance between TST (cut off 10 mm) and QFT results
QFT test Total
Negative Positive
TST [mm] 0–9 Number 186 41 227
% with TST 10 81.9% 18.1% 100.0%
% with QFT 0.35 57.1% 32.5% 50.2%
10+ Number 140 85 225
% with TST 10 62.2% 37.8% 100.0%
% with QFT 0.35 42.9% 67.5% 49.8%
Total Number 326 126 452
% with TST 10 72.1% 27.9% 100.0%
% with QFT 0.35 100.0% 100.0% 100.0%
Assesment  of agreement Value Standard error T(b) p
Assesment                         Kappa .198 .041 4.674 .000
of agreement
N 452
Table 8. Concordance between TST (cut off 15 mm) and QFT results
QFT test Total
Negative Positive
TST [mm] 0–14 Number 271 65 336
% with TST 15 80.7% 19.3% 100.0%
% with QFT 0.35 83.1% 51.6% 74.3%
15+ Number 55 61 116
% with TST 15 47.4% 52.6% 100.0%
% with QFT 0.35 16.9% 48.4% 25.7%
Total Number 326 126 452
% with TST 15 72.1% 27.9% 100.0%
% with QFT 0.35 100.0% 100.0% 100.0%
Assesment of agreement Value Standard error p
Assesment of agreement                                   Kappa .323 .049 .000
N 452
centages of subjects with positive QFT test results
was much lower and did not exceed 10% in the
group under 24 years and 20% in the group 25–44
years old.
When TST diameter of 15 mm or more was
considered a positive result, higher concordance
between the TST and QFT test results was obse-
rved in individual age groups than in the case of
diameter of 10 mm or more.
Discussion
One of the most important indicators of epide-
miological status of tuberculosis are the annual infec-
tion risk and the percentage of individuals infected
with M. tuberculosis, as they constitute the source pool
for new cases of the disease. An efficient test for the
detection of latent tuberculosis infection should iden-
tify individuals at high risk of tuberculosis in the fu-
ture. This condition is met by tests based on the me-
asurement of interferon secretion by the subject’s lym-
phocytes stimulated by antigens specific to M. tuber-
culosis (Interferon-Gamma Release Assays , IGRAs).
Higuchi et al. [13] observed that during a follow-up
(lasting more than 3 years) of 84 subjects who had been
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Figure 2. Percentage of infected based on positive QFT and TST results related to the incidence of TB different age groups
Table 9. Condordance between TST (cut off 10 mm) and QFT results in different age groups
Assesment of agreement Value Standard error p
Age group/Years £ 24 k .087 .086 .317
N 43
25–44 k .163 .051 .002
N 166
45–59 k .273 .070 .000
N 166
≥  60 k .322 .103 .003
N 77
Figure 1. ROC curve for TST diameter versus QFT results
in close contact with tuberculosis patients and had
positive TST results but negative QFT test results,
none of the subjects develop active tuberculosis. In
the study conducted by Diel et al. [4], only 2.3% of
subjects with positive TST result and as much as
14.6% of subjects with positive QFT test results deve-
lop active tuberculosis during a 2-year follow-up of
individuals exposed to tuberculosis. No cases of tu-
berculosis were observed in the group of subjects with
negative QFT and positive TST results, despite the
exposure to sputum-positive patients, with the QFT
test results being independent of previous BCG vacci-
nation of patients [4].
If the QFT test is specific for M. tuberculosis
infection, it should be significantly age-dependent
because in countries with tuberculosis incidence
systematically decreasing, the incidence is shifted
towards older age groups [8, 9]. Poland is one such
country, where data acquired from the tuberculo-
sis incidence registry show a decidedly lower in-
cidence in younger age groups. The incidence rate
in the Mazowieckie province is nearly 7 times lo-
wer in the age group of 15–19 years than in the age
group of 65 years and more [8, 9].
Positive QFT test results were observed in
23.3% of subjects in the study population. The
percentage of individuals with positive QFT test
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results increased with age in a statistically signifi-
cant manner (from 7.1% in the under 24 group to
48.8% in the 60 and more group). Multiple regres-
sion analysis revealed that the odds ratio, i.e. the
possibility of being infected with M. tuberculosis,
was about 5 times higher in individuals above 45
years of age and 12 times higher in individuals
above 60 years of age, compared to individuals
under 24 years of age. The usefulness of the QFT
test as a tool for the detection of tuberculosis in-
fection is supported by the trend of increasing pre-
valence of positive results with age. This trend is
consistent with the incidence of tuberculosis in-
fections, while the opposite is true in the case of
prevalence of positive TST results (Figure 2).
The results of studies conducted by the au-
thors of this work suggest that the QFT test shows
a high consistency with the estimated numbers of
infected individuals in Poland.
The analysis of the usefulness of the TST in
diagnosing tuberculosis infections was conducted
in the study population for two cut-off values: 10
mm or above and 15 mm or above. Positive TST
results for the diameter of 10 mm or above were
much more common than positive QFT test results
(50.3% vs. 23.3%). In addition, positive TST results
were observed with similarly high frequencies in
the youngest and the medium age groups. Similar
results were obtained by other authors [14, 15],
which may be explained by positive reaction to
tuberculin due to exposure to non-tuberculous ba-
cilli in the environment or due to previous multi-
ple BCG vaccinations. Anti-tuberculosis vaccina-
tions result in limitation of TST specificity [16].
In populations, in which multiple BCG vaccina-
tions were performed in line with vaccination sche-
dules, as was until recently the case in Poland,
specificity of TSTs is particularly low. In studies
conducted by Pai et al. [17], specificity was 59%.
A very large meta-analysis of studies including a
total of more than 250 000 subjects showed that
TST rarely produces positive results at 10 years
after vaccination in populations having received a
single vaccination immediately after birth (1%),
while positive results are found 10 years after vac-
cination in as much as 21.2% of subjects if vacci-
nations were repeated after the 1st year of life [18].
Based on these studies, one may draw the conclu-
sion that BCG revaccination performed after the 1st
year of life is the cause of positive TST results per-
sisting for many years. Such is the case in Poland,
where, according to the vaccination schedule in
force until 2005, BCG vaccination was repeated
every several years until the age of 18. Due to false-
positive results resulting from post-vaccination re-
actions and exposure to non-tuberculous bacilli, the
usefulness of TST in the detection of tuberculosis
infection is a subject of scepticism.
Data are available suggesting that the larger
the diameter of the infiltration, the higher the pro-
bability of infection; therefore, many authors con-
sider infiltrations of 15 mm or above to indicate
a positive result. The results of this study, sho-
wing a higher consistency with QFT test results
for positive TST results of 15 mm than for 10 mm,
confirm that the 15-mm cut-off value is more spe-
cific. Meta-analysis of studies of the impact of
BCG vaccinations on TST diameter showed that
infiltrations with a diameter of 15 mm or more are
due to M. tuberculosis infection, and not BCG vac-
cination [2]. However, it must be mentioned that,
although the specificity of the test increases with
the increasing TST infiltration diameter as the
criterion for the positive result, test sensitivity
decreases significantly, as evidenced by ROC in
the test material.
The study showed that, contrary to the QFT
test, the tuberculin skin test produced more com-
mon negative results in the age group above 60
years of age compared to the remaining age gro-
ups. Infiltrations with the diameters of 15 mm or
larger were observed only in 14.1% patients aged
Table 10. Concordance between TST (cut off 15 mm) and QFT results in different age groups
Assesment of agreement Value Standard error p
Age group/Years £ 24 k .205 .174 .133
N 43
25–44 k .393 .083 .000
N 166
45–59 k .364 .076 .000
N 166
≥ 60 k .213 .076 .006
N 77
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60 or older. This result is markedly lower than the
estimated infection rate.
The disappearance of tuberculin reactivity in
elderly subjects is known in the literature [12, 19]
and is explained by poorer efficiency of the immu-
ne system in the elderly and by poorer reactivity
of skin itself [12, 19, 20]. In their study on silicose
patients, Leung et al. [21] showed that in elderly
subjects above the age of 65, TST results were ne-
gative more frequently than in the group of youn-
ger subjects, while the results of IGRA tests were
positive in older and younger subjects with simi-
lar frequencies.
Therefore, the TST was not a good indicator
of tuberculosis infection in the population of this
study as the percentage of positive results signifi-
cantly exceeded the percentage of infected patients
estimated on the basis of the register of incidence,
showed no age-dependent differentiation, and de-
creased significantly at the age of over 60, altho-
ugh theoretically, latent infections with M. tuber-
culosis should be more common in the elderly. This
shows that in the study population, the usefulness
of the positive TST result of 10 mm as an indica-
tor of the infection is very limited.
The prognostic value of TST results depending
on size of induration is unclear [22]. Canadian stu-
dies on contacts with sputum-positive patients sho-
wed that the risk of infection increases with the
TST diameter, suggesting that the size of the infil-
tration may matter; however, a more thorough ana-
lysis showed that the exposure to a sputum-posi-
tive patient is most important. The risk of infec-
tion following a close, domestic exposure was high
even for small infiltration sizes of 0-4 mm, while
in the case of out-of-home exposure, significance
could be attributed to infiltrations of 10 mm or
more [23].
The concordance between the TST and the
QFT test in this study was very poor if TST results
of 10 mm or more were considered positive (κ
0.198), and significantly better when the positive
result cut-off value was 15 mm (k 0.323). The po-
orest concordance between both tests was observed
in younger age groups (≥ 24 and 25–44 years), in
which the percentages of subjects with positive
TST results were high and exceeded 50% for the
cut-off diameter of 10 mm, while the percentages
of subjects with positive QFT test results in these
groups was much lower and did not exceed 10%
in the under 24 years group and 20% in the 25–44
years group. Very poor agreement between the TST
and QFT test results was reported by other authors
[3, 20, 24, 25].
One of the goals of the study was to evaluate
the impact of environmental factors on the inci-
dence of tuberculosis infections. The study showed
that the highest percentage of individuals with
positive QFT test and TST results (regardless of
cut-off value) was observed in healthcare profes-
sionals and was significantly higher than in the
ZDR group (QFT 32.2% vs. 20.4%; p < 0.01). The
incidence of M. tuberculosis infection assessed by
means of the QFT test in the group of inmates was
the same as in the ZDR group, i.e. in individuals
from outside the healthcare professions or peniten-
tiaries.
Conclusions
1. Latent infections with M. tuberculosis defined
by positive QFT test results were much less
common in the study group compared to when
a positive TST result was considered to be the
diagnostic criterion. The incidence of latent in-
fection defined by the positive QFT result was
similar to estimates derived from the tubercu-
losis morbidity register according to the Sty-
blo principle.
2. The incidence of infections with M. tubercu-
losis as assessed by the QFT test was age-de-
pendent and significantly lower among young
subjects (7.1%) compared to older subjects
(48.8%) and thus in line with the tuberculo-
sis incidence trends.
3. The usefulness of TST in diagnostics of latent
tuberculosis infection was poor. This might be
due to false-positive post-vaccination reac-
tions, particularly in younger age groups, and
false-negative reactions in elderly patients,
most probably due to anergy.
4. The concordance between the TST and QFT
test results was very low if TST infiltration of
10 mm or more was considered to be a positi-
ve result, and higher when the positive result
cut-off value was 15 mm.
5. The incidence of latent tuberculosis infection
in healthcare professionals as measured by the
QFT test was significantly higher than in in-
dividuals from outside this group (32.2% vs.
20.4%; p  0.01).
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